1887

Abstract

T-cell recognition of the secreted and membrane-bound portions of the herpes simplex virus type 2 (HSV-2) glycoprotein G (sgG-2 and mgG-2, respectively) was compared in symptomatic and asymptomatic HSV-2-infected individuals and in HSV-2-seronegative controls and the responses with HSV-1 glycoproteins C and E (gC-1 and gE-1) were compared. CD4 T cells from HSV-2-infected individuals specifically recognized both sgG-2 and mgG-2, whereas HSV-1-infected and HSV-seronegative controls did not respond to these glycoproteins. The responses to gC-1 and gE-1, on the other hand, were not type specific, as blood mononuclear cells from both HSV-1- and HSV-2-infected individuals responded . There was an association between the status of the infection (symptomatic versus asymptomatic) and the CD4 T-cell responsiveness. Symptomatic HSV-2-seropositive individuals responded with significantly lower Th1 cytokine production to sgG-2 and mgG-2 than did asymptomatic HSV-2-infected carriers, especially within the HSV-1-negative cohort. No differences in T-cell proliferation were observed between asymptomatic and symptomatic individuals. The results have implications for studies of HSV-2-specific CD4 T-cell reactivity in general and for analysis of immunological differences between asymptomatic and symptomatic individuals in particular.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.79978-0
2004-08-01
2019-11-17
Loading full text...

Full text loading...

/deliver/fulltext/jgv/85/8/vir852139.html?itemId=/content/journal/jgv/10.1099/vir.0.79978-0&mimeType=html&fmt=ahah

References

  1. Ahmed, H. J., Mbwana, J., Gunnarsson, E., Ahlman, K., Guerino, C., Svensson, L., Mhalu, F. & Lagergard, T. ( 2003; ). Etiology of genital ulcer disease and association with human immunodeficiency virus infection in two Tanzanian cities. Sex Transm Dis 30, 114–119.[CrossRef]
    [Google Scholar]
  2. Augenbraun, M., Feldman, J., Chirgwin, K., Zenilman, J., Clarke, L., DeHovitz, J., Landesman, S. & Minkoff, H. ( 1995; ). Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women. Ann Intern Med 123, 845–847.[CrossRef]
    [Google Scholar]
  3. Balachandran, N. & Hutt-Fletcher, L. M. ( 1985; ). Synthesis and processing of glycoprotein gG of herpes simplex virus type 2. J Virol 54, 825–832.
    [Google Scholar]
  4. Belkaid, Y., Piccirillo, C. A., Mendez, S., Shevach, E. M. & Sacks, D. L. ( 2002; ). CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502–507.[CrossRef]
    [Google Scholar]
  5. Bergström, T., Sjögren-Jansson, E., Jeansson, S. & Lycke, E. ( 1992; ). Mapping neuroinvasiveness of the herpes simplex virus type 1 encephalitis-inducing strain 2762 by the use of monoclonal antibodies. Mol Cell Probes 6, 41–49.[CrossRef]
    [Google Scholar]
  6. Biron, C. A., Byron, K. S. & Sullivan, J. L. ( 1989; ). Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320, 1731–1735.[CrossRef]
    [Google Scholar]
  7. Burchett, S. K., Corey, L., Mohan, K. M., Westall, J., Ashley, R. & Wilson, C. ( 1992; ). Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J Infect Dis 165, 813–818.[CrossRef]
    [Google Scholar]
  8. Carmack, M. A., Yasukawa, L. L., Chang, S. Y., Tran, C., Saldana, F., Arvin, A. M. & Prober, C. G. ( 1996; ). T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2. J Infect Dis 174, 899–906.[CrossRef]
    [Google Scholar]
  9. Cauda, R., Laghi, V., Tumbarello, M., Ortona, L. & Whitley, R. J. ( 1989; ). Immunological alterations associated with recurrent herpes simplex genitalis. Clin Immunol Immunopathol 51, 294–302.[CrossRef]
    [Google Scholar]
  10. Ching, C. & Lopez, C. ( 1979; ). Natural killing of herpes simplex virus type 1-infected target cells: normal human responses and influence of antiviral antibody. Infect Immun 26, 49–56.
    [Google Scholar]
  11. Cunningham, A. L., Turner, R. R., Miller, A. C., Para, M. F. & Merigan, T. C. ( 1985; ). Evolution of recurrent herpes simplex virus lesions. J Clin Invest 75, 226–233.[CrossRef]
    [Google Scholar]
  12. Dall'Olio, F., Malagolini, N., Campadelli-Fiume, G. & Serafini-Cessi, F. ( 1987); . Glycosylation pattern of herpes simplex virus type 2 glycoprotein G from precursor species to the mature form. Arch Virol 97, 237–249.[CrossRef]
    [Google Scholar]
  13. de la Calle-Martin, O., Hernandez, M., Ordi, J. & 7 other authors ( 2001; ). Familial CD8 deficiency due to a mutation in the CD8 alpha gene. J Clin Invest 108, 117–123.[CrossRef]
    [Google Scholar]
  14. de la Salle, H., Zimmer, J., Fricker, D. & 8 other authors ( 1999; ). HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. J Clin Invest 103, R9–R13.[CrossRef]
    [Google Scholar]
  15. Forsgren, M., Skoog, E., Jeansson, S., Olofsson, S. & Giesecke, J. ( 1994; ). Prevalence of antibodies to herpes simplex virus in pregnant women in Stockholm in 1969, 1983 and 1989: implications for STD epidemiology. Int J STD AIDS 5, 113–116.
    [Google Scholar]
  16. Frenkel, L. M., Garratty, E. M., Shen, J. P., Wheeler, N., Clark, O. & Bryson, Y. J. ( 1993; ). Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med 118, 414–418.[CrossRef]
    [Google Scholar]
  17. Görander, S., Svennerholm, B. & Liljeqvist, J.-Å. ( 2003; ). Secreted portion of glycoprotein G of herpes simplex virus type 2 is a novel antigen for type-discriminating serology. J Clin Microbiol 41, 3681–3686.[CrossRef]
    [Google Scholar]
  18. Harandi, A. M., Svennerholm, B., Holmgren, J. & Eriksson, K. ( 2001; ). Differential roles of B cells and IFN-γ secreting CD4+ T cells in innate and adaptive immune control of genital herpes simplex virus type 2 infection in mice. J Gen Virol 82, 845–853.
    [Google Scholar]
  19. Heise, M. T. & Virgin, H. W., IV ( 1995; ). The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infections. J Virol 69, 904–909.
    [Google Scholar]
  20. Kinghorn, G. R. ( 1994; ). Epidemiology of genital herpes. J Int Med Res 22 (Suppl. 1), 14A–23A.
    [Google Scholar]
  21. Koelle, D. M. & Wald, A. ( 2000; ). Herpes simplex virus: the importance of asymptomatic shedding. J Antimicrob Chemother 45 (Suppl. T3), 1–8.
    [Google Scholar]
  22. Koelle, D. M., Corey, L., Burke, R. L., Eisenberg, R. J., Cohen, G. H., Pichyangkura, R. & Triezenberg, S. J. ( 1994; ). Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J Virol 68, 2803–2810.
    [Google Scholar]
  23. Koelle, D. M., Frank, J. M., Johnson, M. L. & Kwok, W. W. ( 1998a; ). Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions. J Virol 72, 7476–7483.
    [Google Scholar]
  24. Koelle, D. M., Posavad, C. M., Barnum, G. R., Johnson, M. L., Frank, J. M. & Corey, L. ( 1998b; ). Clearance of HSV-2 from recurrent genital lesions correlates with infiltration of HSV-specific cytotoxic T lymphocytes. J Clin Invest 101, 1500–1508.[CrossRef]
    [Google Scholar]
  25. Koelle, D. M., Schomogyi, M. & Corey, L. ( 2000a; ). Antigen-specific T cells localize to the uterine cervix in women with genital herpes simplex virus type 2 infection. J Infect Dis 182, 662–670.[CrossRef]
    [Google Scholar]
  26. Koelle, D. M., Schomogyi, M., McClurkan, C., Reymond, S. N. & Chen, H. B. ( 2000b; ). CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins. J Virol 74, 11422–11425.[CrossRef]
    [Google Scholar]
  27. Kohl, S., Loo, L. S., Drath, D. B. & Cox, P. ( 1989; ). Interleukin-2 protects neonatal mice from lethal herpes simplex virus type 2 infection: a macrophage-mediated, interferon-induced mechanism. J Infect Dis 159, 239–247.[CrossRef]
    [Google Scholar]
  28. Koutsky, L. A., Ashley, R. L., Holmes, K. K., Stevens, C. E., Critchlow, C. W., Kiviat, N., Lipinski, C. M., Wolner-Hanssen, P. & Corey, L. ( 1990; ). The frequency of unrecognized type 2 herpes simplex virus infection among women. Implications for the control of genital herpes. Sex Transm Dis 17, 90–94.[CrossRef]
    [Google Scholar]
  29. Krone, M. R., Wald, A., Tabet, S. R., Paradise, M., Corey, L. & Celum, C. L. ( 2000; ). Herpes simplex virus type 2 shedding in human immunodeficiency virus-negative men who have sex with men: frequency, patterns, and risk factors. Clin Infect Dis 30, 261–267.[CrossRef]
    [Google Scholar]
  30. Langenberg, A., Benedetti, J., Jenkins, J., Ashley, R., Winter, C. & Corey, L. ( 1989; ). Development of clinical recognizable genital lesions among women previously identified as having “asymptomatic” herpes simplex virus type 2 infection. Ann Intern Med 110, 882–887.[CrossRef]
    [Google Scholar]
  31. Langenberg, A. G., Corey, L., Ashley, R. L., Leong, W. P. & Straus, S. E. ( 1999; ). A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N Engl J Med 341, 1432–1438.[CrossRef]
    [Google Scholar]
  32. Lee, F. K., Coleman, R. M., Pereira, L., Bailey, P. D., Tatsuno, M. & Nahmias, A. J. ( 1985; ). Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol 22, 641–644.
    [Google Scholar]
  33. Liljeqvist, J.-Å., Trybala, E., Svennerholm, B., Jeansson, S., Sjögren-Jansson, E. & Bergström, T. ( 1998; ). Localization of type-specific epitopes of herpes simplex virus type 2 glycoprotein G recognized by human and mouse antibodies. J Gen Virol 79, 1215–1224.
    [Google Scholar]
  34. Liljeqvist, J.-Å., Svennerholm, B. & Bergstrom, T. ( 1999; ). Herpes simplex virus type 2 glycoprotein G-negative clinical isolates are generated by single frameshift mutations. J Virol 73, 9796–9802.
    [Google Scholar]
  35. Liljeqvist, J.-Å., Trybala, E., Hoebeke, J., Svennerholm, B. & Bergström, T. ( 2002; ). Monoclonal antibodies and human sera directed to the secreted glycoprotein G of herpes simplex virus type 2 recognize type-specific antigenic determinants. J Gen Virol 83, 157–165.
    [Google Scholar]
  36. Marsden, H. S., Buckmaster, A., Palfreyman, J. W., Hope, R. G. & Minson, A. C. ( 1984; ). Characterization of the 92,000-dalton glycoprotein induced by herpes simplex virus type 2. J Virol 50, 547–554.
    [Google Scholar]
  37. Persson, K., Månsson, A., Jönsson, E. & Nordenfelt, E. ( 1995; ). Decline of herpes simplex virus type 2 and Chlamydia trachomatis infections from 1970 to 1993 indicated by a similar change in antibody pattern. Scand J Infect Dis 27, 195–199.[CrossRef]
    [Google Scholar]
  38. Posavad, C. M., Koelle, D. M., Shaughnessy, M. F. & Corey, L. ( 1997; ). Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses. Proc Natl Acad Sci U S A 94, 10289–10294.[CrossRef]
    [Google Scholar]
  39. Roizman, B., Norrild, B., Chan, C. & Pereira, L. ( 1984; ). Identification and preliminary mapping with monoclonal antibodies of a herpes simplex virus 2 glycoprotein lacking a known type 1 counterpart. Virology 133, 242–247.[CrossRef]
    [Google Scholar]
  40. Schacker, T., Zeh, J., Hu, H. L., Hill, E. & Corey, L. ( 1998; ). Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men. J Infect Dis 178, 1616–1622.[CrossRef]
    [Google Scholar]
  41. Siegal, F. P., Lopez, C., Hammer, G. S. & 11 other authors ( 1981; ). Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 305, 1439–1444.[CrossRef]
    [Google Scholar]
  42. Singh, R., Kumar, A., Creery, W. D., Ruben, M., Giulivi, A. & Diaz-Mitoma, F. ( 2003; ). Dysregulated expression of IFN-γ and IL-10 and impaired IFN-γ-mediated responses at different stages in patients with genital herpes simplex virus-2 infection. Clin Exp Immunol 133, 97–107.[CrossRef]
    [Google Scholar]
  43. Spatz, M., Wolf, H. M., Thon, V., Gampfer, J. M. & Eibl, M. M. ( 2000; ). Immune response to the herpes simplex type 1 regulatory proteins ICP8 and VP16 in infected persons. J Med Virol 62, 29–36.[CrossRef]
    [Google Scholar]
  44. Spruance, S. L., Overall, J. C., Jr, Kern, E. R., Krueger, G. G., Pliam, V. & Miller, W. ( 1977; ). The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med 297, 69–75.[CrossRef]
    [Google Scholar]
  45. Su, H. K., Eberle, R. & Courtney, R. J. ( 1987; ). Processing of the herpes simplex virus type 2 glycoprotein gG-2 results in secretion of a 34,000-Mr cleavage product. J Virol 61, 1735–1737.
    [Google Scholar]
  46. Suri-Payer, E., Amar, A. Z., Thornton, A. M. & Shevach, E. M. ( 1998; ). CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J Immunol 160, 1212–1218.
    [Google Scholar]
  47. Suvas, S., Kumaraguru, U., Pack, C. D., Lee, S. & Rouse, B. T. ( 2003; ). CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med 198, 889–901.[CrossRef]
    [Google Scholar]
  48. Svennerholm, B., Olofsson, S., Jeansson, S., Vahlne, A. & Lycke, E. ( 1984; ). Herpes simplex virus type-selective enzyme-linked immunosorbent assay with Helix pomatia lectin-purified antigens. J Clin Microbiol 19, 235–239.
    [Google Scholar]
  49. Trybala, E., Liljeqvist, J. Å., Svennerholm, B. & Bergström, T. ( 2000; ). Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. J Virol 74, 9106–9114.[CrossRef]
    [Google Scholar]
  50. Tunbäck, P., Liljeqvist, J.-Å., Löwhagen, G.-B. & Bergström, T. ( 2000; ). Glycoprotein G of herpes simplex virus type 1: identification of type-specific epitopes by human antibodies. J Gen Virol 81, 1033–1040.
    [Google Scholar]
  51. van Benthem, B. H., Spaargaren, J., van Den Hoek, J. A., Merks, J., Coutinho, R. A. & Prins, M. ( 2001; ). Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. Sex Transm Infect 77, 120–124.[CrossRef]
    [Google Scholar]
  52. Wald, A., Zeh, J., Selke, S., Ashley, R. L. & Corey, L. ( 1995; ). Virologic characteristics of subclinical and symptomatic genital herpes infections. N Engl J Med 333, 770–775.[CrossRef]
    [Google Scholar]
  53. Wald, A., Corey, L., Cone, R., Hobson, A., Davis, G. & Zeh, J. ( 1997; ). Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest 99, 1092–1097.[CrossRef]
    [Google Scholar]
  54. Wald, A., Zeh, J., Selke, S., Warren, T., Ryncarz, A. J., Ashley, R., Krieger, J. N. & Corey, L. ( 2000; ). Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med 342, 844–850.[CrossRef]
    [Google Scholar]
  55. Wald, A., Zeh, J., Selke, S., Warren, T., Ashley, R. & Corey, L. ( 2002; ). Genital shedding of herpes simplex virus among men. J Infect Dis 186 (Suppl. 1), S34–S39.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.79978-0
Loading
/content/journal/jgv/10.1099/vir.0.79978-0
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error